PROMOMED Public joint-stock company is a leading innovative biopharmaceutical com-pany with attractive growth potential in promising segments of the pharmaceutical market.
The Company has unique R&D Hub and manufacturing plant named BIOKHIMIK. This al-lows PROMOMED to develop innovative medicines, benefit from a full production cycle based on “From Idea, to Molecule, to Patient” concept, be fast in responding to unmet needs in healthcare, implement up-to-date technology solutions.
PROMOMED is ranked #1 in Obesity treatment segment being an expert in metabolic health therapy. The Company is #1 in Russia in terms of the number of clinical trials and medical studies in 2022-2023.The Company is among TOP-3 in the relevant market segments in Onco, Antibiotics, HIV, Hepatitis.
PROMOMED has a diversified portfolio of more than 330 medicines and is represented in all TOP-10 of the biggest and fastest growing therapeutic areas in the local market, such as On-co, Diabetes, Obesity, Neuro, Rheuma, Pain, etc. More than 80% of PROMOMED products are listed as live-saving products in the local Essential Drug List (EDL). The main drivers in the Com-pany's products range are branded pharmaceutical blockbusters, biotech products, innovative small molecules, as well as OTC brands.
The state-of-the-art R&D Hub underpins advanced healthcare solutions and creates a solid background for business development. In addition to laboratories and centers for the develop-ment of Biotech and Small molecules, R&D Hub develops active drug substances, ensures regis-tration service, technology transfers and production scaling, leads market authorization and sup-ports the development of advanced Quality controls methods.
The Company’s deep expertise in the field of innovative chemical technologies and Bio-tech, combined with modern manufacturing plant, allow PROMOMED to occupy leading positions in various professional ratings and ensure her active and important contribution to local Healthcare system
Company Details
- Employees
- 74
- Founded
- -
- Address
- Prospekt Mira, 13 P. 1, Moscow,129090,russian Federation
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- promo-med.ru
- HQ
- Moscow
Promomed Questions
Promomed's website is promo-med.ru
Promomed's LinkedIn profile is https://ru.linkedin.com/company/promo-med
Promomed has
74 employees.
View email and phone details for 74
employees at Promomed.
Promomed's industry is
Pharmaceutical Manufacturing
Promomed's top competitors are
Petrovax Pharm,
Geropharm,
Biocad,
Nanolek,
Pharmasyntez Group Of Companies,
Rus Biopharm,
Solopharm,
Akrikhin,
R-Pharm,
Mirpharm Group Of Pharmaceutical Companies.
Promomed's categories are Pharmaceutical Manufacturing
Promomed's founding year is 2005
